JP2016521683A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016521683A5 JP2016521683A5 JP2016514523A JP2016514523A JP2016521683A5 JP 2016521683 A5 JP2016521683 A5 JP 2016521683A5 JP 2016514523 A JP2016514523 A JP 2016514523A JP 2016514523 A JP2016514523 A JP 2016514523A JP 2016521683 A5 JP2016521683 A5 JP 2016521683A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- group
- fragment
- hydroxytryptophan
- acetic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361827506P | 2013-05-24 | 2013-05-24 | |
| US61/827,506 | 2013-05-24 | ||
| PCT/IB2014/061634 WO2014188377A2 (en) | 2013-05-24 | 2014-05-22 | Pathway specific assays for predicting irritable bowel syndrome diagnosis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019075081A Division JP2019151637A (ja) | 2013-05-24 | 2019-04-10 | 過敏性腸症候群の診断を予測するための経路特異的なアッセイ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016521683A JP2016521683A (ja) | 2016-07-25 |
| JP2016521683A5 true JP2016521683A5 (enExample) | 2017-06-29 |
Family
ID=50884973
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016514524A Pending JP2016520199A (ja) | 2013-05-24 | 2014-05-22 | 過敏性腸症候群を診断するための経路特異的マーカー |
| JP2016514523A Pending JP2016521683A (ja) | 2013-05-24 | 2014-05-22 | 過敏性腸症候群の診断を予測するための経路特異的なアッセイ |
| JP2019075081A Pending JP2019151637A (ja) | 2013-05-24 | 2019-04-10 | 過敏性腸症候群の診断を予測するための経路特異的なアッセイ |
| JP2019104805A Pending JP2019194600A (ja) | 2013-05-24 | 2019-06-04 | 過敏性腸症候群を診断するための経路特異的マーカー |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016514524A Pending JP2016520199A (ja) | 2013-05-24 | 2014-05-22 | 過敏性腸症候群を診断するための経路特異的マーカー |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019075081A Pending JP2019151637A (ja) | 2013-05-24 | 2019-04-10 | 過敏性腸症候群の診断を予測するための経路特異的なアッセイ |
| JP2019104805A Pending JP2019194600A (ja) | 2013-05-24 | 2019-06-04 | 過敏性腸症候群を診断するための経路特異的マーカー |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US9891235B2 (enExample) |
| EP (2) | EP3004068A2 (enExample) |
| JP (4) | JP2016520199A (enExample) |
| KR (2) | KR20160010621A (enExample) |
| CN (2) | CN105579852B (enExample) |
| AU (3) | AU2014269960B2 (enExample) |
| BR (2) | BR112015029320A8 (enExample) |
| CA (2) | CA2912993A1 (enExample) |
| HK (1) | HK1223361A1 (enExample) |
| IL (2) | IL242595B (enExample) |
| MX (1) | MX367046B (enExample) |
| RU (2) | RU2015155552A (enExample) |
| SG (2) | SG11201509371XA (enExample) |
| WO (2) | WO2014188378A1 (enExample) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2015155552A (ru) | 2013-05-24 | 2017-06-27 | Нестек С.А. | Путеспецифические способы прогнозирования диагноза синдрома раздраженного кишечника |
| BR112015032033A2 (pt) | 2013-06-21 | 2017-08-29 | Ondek Pty Ltd | Composição de imunoterapia e uso da mesma |
| CN106573065A (zh) * | 2014-05-09 | 2017-04-19 | 诺格尔制药有限公司 | 用于治疗炎症性肠病的方法 |
| JP2018501202A (ja) | 2014-11-19 | 2018-01-18 | ネステク ソシエテ アノニム | セロトニン、トリプトファン、及びキヌレニンの代謝産物に対する抗体及びその使用 |
| MX375863B (es) | 2014-11-19 | 2025-03-07 | Nzp Uk Ltd | Esteroides de 6-alquil-7-hidroxi-4-en-3-ona como intermedios para la produccion de moduladores esteroideos del receptor x farnesoide (fxr) |
| EA033603B1 (ru) | 2014-11-19 | 2019-11-08 | Nzp Uk Ltd | 6-альфа-алкил-6,7-дионовые стероиды в качестве промежуточных соединений для получения стероидных модуляторов fxr |
| CN107108688B (zh) | 2014-11-19 | 2019-10-29 | Nzp英国有限公司 | 作为制备类固醇FXR调节剂的中间体的6α-烷基-3,7-二酮类固醇 |
| TWI686400B (zh) | 2014-11-19 | 2020-03-01 | 英商Ｎｚｐ英國有限公司 | 化合物（二） |
| HK1244881A1 (zh) * | 2014-12-02 | 2018-08-17 | Société des Produits Nestlé S.A. | 建立维多珠单坑给药方案以治疗患有易激惹肠病的患者的方法 |
| CN105987995A (zh) * | 2015-02-04 | 2016-10-05 | 东莞博捷生物科技有限公司 | 一种检测人抗酿酒酵母IgG类抗体的酶联免疫试剂盒 |
| CN105987996A (zh) * | 2015-02-09 | 2016-10-05 | 东莞博捷生物科技有限公司 | 一种检测人抗酿酒酵母IgA类抗体的酶联免疫试剂盒 |
| CN105061305A (zh) * | 2015-08-31 | 2015-11-18 | 河南师范大学 | 一步合成3-甲基-2-吡啶甲酸甲酯的方法 |
| GB201608777D0 (en) | 2016-05-18 | 2016-06-29 | Dextra Lab Ltd | Compounds |
| CN106399344B (zh) * | 2016-06-01 | 2021-01-01 | 上海领潮生物新材料有限公司 | 一种vin-cdtb融合蛋白的制备方法 |
| WO2018011691A1 (en) * | 2016-07-12 | 2018-01-18 | Nestec S.A. | Competitive immunoassay methods |
| CN106188191A (zh) * | 2016-07-13 | 2016-12-07 | 西安电子科技大学 | 基于gsh响应的诊治一体化有机分子探针及其制备方法 |
| US11959125B2 (en) | 2016-09-15 | 2024-04-16 | Sun Genomics, Inc. | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
| US10428370B2 (en) | 2016-09-15 | 2019-10-01 | Sun Genomics, Inc. | Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample |
| EP3512946A4 (en) * | 2016-09-15 | 2020-04-08 | Sun Genomics Inc. | UNIVERSAL METHOD FOR EXTRACTING NUCLEIC ACID MOLECULES FROM A DIVERSE POPULATION OF ONE OR MORE TYPES OF MICROBES IN A SAMPLE |
| EP3551047A1 (en) | 2016-12-07 | 2019-10-16 | Progenity, Inc. | Gastrointestinal tract detection methods, devices and systems |
| CA3045310A1 (en) | 2016-12-14 | 2018-06-21 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor |
| JP7150723B2 (ja) | 2016-12-14 | 2022-10-11 | ビオラ・セラピューティクス・インコーポレイテッド | 消化管疾病のインテグリン阻害薬による治療 |
| WO2018112256A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with an il-1 inhibitor |
| CA3047302C (en) * | 2016-12-14 | 2024-01-02 | Tracy WARREN | System and methods for developing and using a microbiome-based action component for patient health |
| WO2018112232A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with an il-12/il-23 inhibitor released using an ingestible device |
| TW201834711A (zh) | 2016-12-14 | 2018-10-01 | 美商寶珍那提公司 | 以tnf抑制劑治療胃腸道疾病 |
| CA3046023A1 (en) | 2016-12-14 | 2018-06-21 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immunosuppressant |
| CA3046019A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with a tlr modulator |
| US11978543B2 (en) | 2016-12-14 | 2024-05-07 | Astarte Medical Partners Inc. | System and methods for developing and using a microbiome-based action component |
| WO2018112235A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with a smad7 inhibitor |
| EP4190318A1 (en) | 2016-12-14 | 2023-06-07 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with a jak inhibitor and devices |
| WO2018112237A1 (en) | 2016-12-14 | 2018-06-21 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with an il-6r inhibitor |
| US11596670B2 (en) | 2017-03-30 | 2023-03-07 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with IL-10 or an IL-10 agonist |
| WO2018183932A1 (en) | 2017-03-30 | 2018-10-04 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with a il-13 inhibitor |
| WO2018183934A1 (en) | 2017-03-30 | 2018-10-04 | Progenity Inc. | Treatment of a disease of the gastrointestinal tract with a chst15 inhibitor |
| AU2018244922A1 (en) | 2017-03-30 | 2019-09-12 | Biora Therapeutics, Inc. | Treatment of a disease of the gastrointestinal tract with live biotherapeutics |
| US20210138213A1 (en) | 2017-03-30 | 2021-05-13 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with an immune modulatory agent released using an ingestible device |
| US20200306516A1 (en) | 2017-08-14 | 2020-10-01 | Progenity, Inc. | Treatment of a disease of the gastrointestinal tract with glatiramer or a pharmaceutically acceptable salt thereof |
| WO2019155071A1 (en) * | 2018-02-09 | 2019-08-15 | Metabolomic Diagnostics Limited | A system and method of generating a model to detect, or predict the risk of, an outcome |
| KR102699211B1 (ko) * | 2018-03-19 | 2024-08-26 | 후지필름 가부시키가이샤 | 정신 질환의 판정 방법 |
| CN112020651A (zh) * | 2018-04-24 | 2020-12-01 | 根特大学 | 用于家禽肠道健康的肠道和粪便生物标志物 |
| JP7421504B2 (ja) | 2018-06-01 | 2024-01-24 | ビオラ・セラピューティクス・インコーポレイテッド | 胃腸のマイクロバイオームの検出および操作のためのデバイスおよびシステム |
| AU2019281024A1 (en) * | 2018-06-07 | 2020-12-24 | 4D Pharma Plc | Method for stratifying IBS patients |
| CN110607335B (zh) * | 2018-06-14 | 2021-08-03 | 中国科学院微生物研究所 | 一种烟酰胺腺嘌呤二核苷酸类化合物生物合成方法 |
| CN109324132A (zh) * | 2018-10-31 | 2019-02-12 | 杭州佰辰医学检验所有限公司 | 高通量检测色氨酸及其代谢产物的试剂盒及其应用 |
| US11488699B1 (en) | 2018-12-09 | 2022-11-01 | Cerner Innovation, Inc. | Microbiota activity sensor and decision support tool |
| US11842795B1 (en) * | 2018-12-17 | 2023-12-12 | Cerner Innovation, Inc. | Irritable bowel syndrome diagnostic sensor and decision support tool |
| FR3094492A1 (fr) * | 2019-04-01 | 2020-10-02 | Polyneuros | Procédé de détection ou de suivi de l’évolution d’une maladie chronique dégénérative par dosage immunologique |
| CN114127317A (zh) * | 2019-04-03 | 2022-03-01 | 4D制药科克有限公司 | 诊断疾病的方法 |
| JPWO2020213732A1 (ja) * | 2019-04-18 | 2021-04-30 | 株式会社サイキンソー | 過敏性腸症候群の検査方法 |
| US11884958B2 (en) * | 2019-04-30 | 2024-01-30 | Mayo Foundation For Medical Education And Research | Assessing and treating functional gastrointestinal disorders |
| WO2020232125A1 (en) | 2019-05-14 | 2020-11-19 | Prometheus Biosciences, Inc. | Tl1a patient selection methods, systems, and devices |
| WO2020232262A1 (en) * | 2019-05-16 | 2020-11-19 | Procisedx Inc. | Assay detection methods for vcam-1 and calprotectin |
| CN111351870A (zh) * | 2019-12-03 | 2020-06-30 | 康美华大基因技术有限公司 | 一种肠易激综合征血清代谢标记物组合及其诊断试剂盒 |
| WO2021151942A1 (en) | 2020-01-27 | 2021-08-05 | Immundiagnostik Ag | Test and in vitro diagnosis of irritable bowel syndrome |
| WO2021152586A1 (en) * | 2020-01-30 | 2021-08-05 | Yeda Research And Development Co. Ltd. | Methods of analyzing microbiome, immunoglobulin profile and physiological state |
| EP3913371A1 (en) | 2020-05-18 | 2021-11-24 | Neuroimmun GmbH | Method and kit for diagnosting irritable bowel syndrome and for its relief through dietary interventions |
| KR102478205B1 (ko) * | 2020-09-24 | 2022-12-15 | 경희대학교 산학협력단 | 크론병 환자에서 상부위장관 침범 진단을 위한 정보 제공 방법 |
| CN114755313B (zh) * | 2021-01-08 | 2024-08-30 | 复旦大学附属华山医院 | 包含尿液nad+代谢物的急性肾损伤标志物 |
| CN115724779B (zh) * | 2021-09-01 | 2024-03-29 | 四川大学 | 酰胺烷二硫化合物、其制备方法和用途 |
| JP2025500321A (ja) * | 2021-12-24 | 2025-01-09 | クレオン リミティド ライアビリティ カンパニー | 多脚型セロトニン作動性化合物ならびにセロトニン受容体アゴニスト及びアンタゴニストのプロドラッグ |
| WO2023180899A1 (en) * | 2022-03-21 | 2023-09-28 | Swain Manish Kumar | Device and method for detecting diarrhea |
| CN116381222A (zh) * | 2023-03-23 | 2023-07-04 | 北京巴瑞医疗器械有限公司 | 一种血清素发光免疫检测方法及血清素检测试剂盒 |
| CN116990498B (zh) * | 2023-09-28 | 2024-08-09 | 山东大学齐鲁医院 | 血浆色氨酸代谢物在儿童偏头痛诊断中的应用 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4676980A (en) | 1985-09-23 | 1987-06-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Target specific cross-linked heteroantibodies |
| US5571894A (en) | 1991-02-05 | 1996-11-05 | Ciba-Geigy Corporation | Recombinant antibodies specific for a growth factor receptor |
| FI941572L (fi) | 1991-10-07 | 1994-05-27 | Oncologix Inc | Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä |
| WO1993008829A1 (en) | 1991-11-04 | 1993-05-13 | The Regents Of The University Of California | Compositions that mediate killing of hiv-infected cells |
| ATE419355T1 (de) | 1992-02-06 | 2009-01-15 | Novartis Vaccines & Diagnostic | Marker für krebs und biosynthetisches bindeprotein dafür |
| ATE149570T1 (de) | 1992-08-17 | 1997-03-15 | Genentech Inc | Bispezifische immunoadhesine |
| US5731168A (en) | 1995-03-01 | 1998-03-24 | Genentech, Inc. | Method for making heteromultimeric polypeptides |
| US5641870A (en) | 1995-04-20 | 1997-06-24 | Genentech, Inc. | Low pH hydrophobic interaction chromatography for antibody purification |
| US6218129B1 (en) * | 1998-05-15 | 2001-04-17 | Prometheus Laboratories, Inc. | Inflammatory bowel disease first step assay system |
| US6406862B1 (en) | 1998-10-06 | 2002-06-18 | The United States Of America As Represented By The Secretary Of The Army | Dip-stick assay for C-reactive protein |
| KR20020063228A (ko) * | 1999-12-15 | 2002-08-01 | 큐비스트 파마슈티컬즈 인코포레이티드 | 항균제로서 리포펩티드 |
| US6838250B2 (en) | 2000-03-31 | 2005-01-04 | Ortho-Clinical Diagnostics, Inc. | Immunoassay for C-reactive protein |
| DE10121217A1 (de) * | 2001-04-30 | 2002-10-31 | Merck Patent Gmbh | 6H-Oxazolo[4,5-e]indol-Derivate als nikotinische Acetylcholinrezeptor Liganden und/oder serotonerge Liganden |
| EP1687447A4 (en) | 2003-11-03 | 2008-04-02 | Univ Duke | METHOD FOR IDENTIFYING INDIVIDUALS IN THE HAZARD OF PERIOPERATIVE BLOODING, A KIDNEY PROBLEM OR A STROKE |
| US20060154276A1 (en) * | 2004-05-13 | 2006-07-13 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
| US20060019410A1 (en) | 2004-07-21 | 2006-01-26 | Qualyst, Inc. | Apparatus, kits and methods for evaluating binding interactions, for detecting and quantifying binding molecules, and for sample preparation |
| WO2007000046A1 (en) * | 2005-06-27 | 2007-01-04 | Holburn Biomedical Corporation | Methods for diagnosing functional bowel disease |
| US7873479B2 (en) | 2005-12-01 | 2011-01-18 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
| US20080085524A1 (en) * | 2006-08-15 | 2008-04-10 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| US20100094560A1 (en) | 2006-08-15 | 2010-04-15 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| US8278057B2 (en) | 2007-09-14 | 2012-10-02 | Nestec S.A. | Addressable antibody arrays and methods of use |
| US20120171672A1 (en) | 2009-04-14 | 2012-07-05 | Prometheus Laboratories Inc. | Inflammatory bowel disease prognostics |
| CA2758531C (en) | 2009-04-14 | 2018-11-13 | Derren Barken | Inflammatory bowel disease prognostics |
| CA2766157A1 (en) * | 2009-06-25 | 2010-12-29 | Hua Gong | Methods for diagnosing irritable bowel syndrome |
| EP2494074A4 (en) * | 2009-10-30 | 2013-06-12 | Nestec Sa | METHOD FOR DIAGNOSING IRRITATION SYNDROME |
| PH12012501016A1 (en) * | 2009-11-25 | 2013-01-14 | Prometheus Laboratories Inc | Novel genomic biomarkers for irritable bowel syndrome diagnosis |
| US8445215B1 (en) * | 2010-07-23 | 2013-05-21 | Nestec S.A. | Assays and methods for the detection of Crohn's disease |
| EP2710383B1 (en) * | 2011-05-16 | 2017-01-11 | The University of Newcastle | Performance of a biomarker panel for irritable bowel syndrome |
| SG11201401536QA (en) | 2011-10-21 | 2014-05-29 | Nestec Sa | Methods for improving inflammatory bowel disease diagnosis |
| JP6329553B2 (ja) * | 2012-10-05 | 2018-05-23 | ネステク ソシエテ アノニム | Ｉｂｓの診断マーカーとしての微生物バイオームに対する抗体、ストレス因子及びマスト細胞マーカー |
| RU2015155552A (ru) | 2013-05-24 | 2017-06-27 | Нестек С.А. | Путеспецифические способы прогнозирования диагноза синдрома раздраженного кишечника |
| TW202446953A (zh) * | 2013-12-04 | 2024-12-01 | 日商中外製藥股份有限公司 | 因應化合物濃度使抗原結合能力變化的抗原結合分子及其資料庫 |
-
2014
- 2014-05-22 RU RU2015155552A patent/RU2015155552A/ru unknown
- 2014-05-22 HK HK16111564.5A patent/HK1223361A1/zh unknown
- 2014-05-22 KR KR1020157036482A patent/KR20160010621A/ko not_active Ceased
- 2014-05-22 WO PCT/IB2014/061636 patent/WO2014188378A1/en not_active Ceased
- 2014-05-22 JP JP2016514524A patent/JP2016520199A/ja active Pending
- 2014-05-22 AU AU2014269960A patent/AU2014269960B2/en not_active Ceased
- 2014-05-22 BR BR112015029320A patent/BR112015029320A8/pt not_active Application Discontinuation
- 2014-05-22 MX MX2015016196A patent/MX367046B/es active IP Right Grant
- 2014-05-22 CN CN201480041527.7A patent/CN105579852B/zh not_active Expired - Fee Related
- 2014-05-22 CN CN201480041536.6A patent/CN105392780A/zh active Pending
- 2014-05-22 BR BR112015029318A patent/BR112015029318A2/pt not_active Application Discontinuation
- 2014-05-22 JP JP2016514523A patent/JP2016521683A/ja active Pending
- 2014-05-22 SG SG11201509371XA patent/SG11201509371XA/en unknown
- 2014-05-22 EP EP14731062.7A patent/EP3004068A2/en not_active Withdrawn
- 2014-05-22 CA CA2912993A patent/CA2912993A1/en not_active Abandoned
- 2014-05-22 RU RU2015155590A patent/RU2015155590A/ru not_active Application Discontinuation
- 2014-05-22 WO PCT/IB2014/061634 patent/WO2014188377A2/en not_active Ceased
- 2014-05-22 SG SG11201509370UA patent/SG11201509370UA/en unknown
- 2014-05-22 KR KR1020157036487A patent/KR20160013163A/ko not_active Ceased
- 2014-05-22 AU AU2014269961A patent/AU2014269961A1/en not_active Abandoned
- 2014-05-22 EP EP14728346.9A patent/EP3004892B1/en not_active Not-in-force
- 2014-05-22 CA CA2913108A patent/CA2913108A1/en not_active Abandoned
-
2015
- 2015-11-11 US US14/938,710 patent/US9891235B2/en not_active Expired - Fee Related
- 2015-11-11 US US14/938,729 patent/US9739786B2/en not_active Expired - Fee Related
- 2015-11-15 IL IL242595A patent/IL242595B/en not_active IP Right Cessation
- 2015-11-15 IL IL242597A patent/IL242597B/en not_active IP Right Cessation
-
2017
- 2017-07-11 US US15/646,838 patent/US10036759B2/en active Active
- 2017-12-19 US US15/847,406 patent/US20180136233A1/en not_active Abandoned
-
2018
- 2018-06-29 US US16/024,183 patent/US10338083B2/en active Active
- 2018-08-09 AU AU2018214104A patent/AU2018214104A1/en not_active Abandoned
-
2019
- 2019-04-10 JP JP2019075081A patent/JP2019151637A/ja active Pending
- 2019-06-04 JP JP2019104805A patent/JP2019194600A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016521683A5 (enExample) | ||
| RU2015155552A (ru) | Путеспецифические способы прогнозирования диагноза синдрома раздраженного кишечника | |
| JP2017524725A5 (enExample) | ||
| JP2016511254A5 (enExample) | ||
| AR080291A1 (es) | Anticuerpos antagonistas anti receptor de il-7 y procedimientos | |
| UA114108C2 (uk) | Моноклональне антитіло для застосування в діагностиці і терапії злоякісних пухлин і аутоімунного захворювання | |
| EA201490677A1 (ru) | Связывающие антиген cd27l белки | |
| JP2018504105A5 (enExample) | ||
| EA201001139A1 (ru) | УЛУЧШЕННЫЕ АНТИТЕЛА АНТИ-TrkB | |
| JP2019523651A5 (enExample) | ||
| CY1118829T1 (el) | Ανασταλτικος vegf σταθερων και διαλυτων αντισωματων | |
| PH12013500890A1 (en) | Methods of treating rheumatoid arthritis using il-17 antagonists | |
| JP2017505622A5 (enExample) | ||
| JP2018042573A5 (enExample) | ||
| EA201692192A1 (ru) | СВЯЗЫВАЮЩЕЕСЯ С FcRn АНТИТЕЛО ДЛЯ ЛЕЧЕНИЯ АУТОИММУННЫХ ЗАБОЛЕВАНИЙ | |
| JP2018526642A5 (enExample) | ||
| JP2016516400A5 (enExample) | ||
| JP2012019790A5 (enExample) | ||
| JP2016536330A5 (enExample) | ||
| JP6827485B2 (ja) | ムスカリン性アセチルコリン受容体の結合剤およびそれらの使用 | |
| IL186948A0 (en) | Monoclonal antibodies and methods for their use in the detection of cervical disease | |
| JP2017532005A5 (enExample) | ||
| JP2014526898A5 (enExample) | ||
| JP2014512812A5 (enExample) | ||
| EA201270491A1 (ru) | Антитела, специфически связывающие рецептор ерна2 |